Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Alcon AG

Healthcare US ALC

66.12USD
0.94(1.44%)

Last update at 2026-06-23T20:00:00Z

Day Range

65.3166.67
LowHigh

52 Week Range

71.5598.85
LowHigh

Fundamentals

  • Previous Close 65.18
  • Market Cap40136.36M
  • Volume2291954
  • P/E Ratio40.56
  • Dividend Yield0.44%
  • EBITDA2331.00M
  • Revenue TTM10401.00M
  • Revenue Per Share TTM21.09
  • Gross Profit TTM 5790.00M
  • Diluted EPS TTM1.98

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1160.00M 1256.00M 832.00M 463.00M 418.00M
Minority interest 0.00000M - - - -
Net income 980.00M 1018.00M 974.00M 335.00M 376.00M
Selling general administrative 3449.00M 3250.00M 3209.00M 3068.00M 3057.00M
Selling and marketing expenses - - - - -
Gross profit 5745.00M 5512.00M 5247.00M 4748.00M 4652.00M
Reconciled depreciation 1335.00M 1228.00M 1221.00M 1123.00M 1219.00M
Ebit 1160.00M 1448.00M 1021.00M 616.59M 539.14M
Ebitda 2351.00M 2676.00M 2242.00M 1776.43M 1760.74M
Depreciation and amortization 1191.00M 1228.00M 1221.00M 1159.84M 1221.59M
Non operating income net other - - - - -
Operating income 1360.00M 1413.00M 1039.00M 672.00M 580.00M
Other operating expenses 9041.00M 8498.00M 8416.00M 8045.00M 7711.00M
Interest expense 204.00M 192.00M 189.00M 134.00M 120.00M
Tax provision 180.00M 238.00M -142.00000M 128.00M 42.00M
Interest income 74.00M 84.00M 45.00M 16.00M 146.00M
Net interest income -142.00000M -120.00000M -155.00000M -146.00000M -162.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 180.00M 238.00M -142.00000M 128.00M 42.00M
Total revenue 10401.00M 9911.00M 9455.00M 8717.00M 8291.00M
Total operating expenses 4385.00M 4099.00M 4208.00M 4076.00M 4072.00M
Cost of revenue 4656.00M 4399.00M 4208.00M 3969.00M 3639.00M
Total other income expense net -200.00000M -157.00000M -207.00000M -209.00000M -162.00000M
Discontinued operations - - - - -
Net income from continuing ops 980.00M 1018.00M 974.00M 335.00M 376.00M
Net income applicable to common shares - - - 335.00M 376.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 31555.00M 30347.00M 29614.00M 29209.00M 27999.00M
Intangible assets 9006.00M 8587.00M 9060.00M 9689.00M 8765.00M
Earning assets - - - - -
Other current assets 509.00M 129.00M 241.96M 418.00M 95.00M
Total liab 9520.00M 8794.00M 8990.00M 9532.00M 8743.00M
Total stockholder equity 22034.00M 21553.00M 20617.02M 19677.00M 19256.00M
Deferred long term liab - - - - 557.00M
Other current liab 1468.00M 1100.16M 1338.20M 1664.00M 1287.00M
Common stock 20.00M 20.00M 19.99M 20.00M 20.00M
Capital stock - 20.00M 20.00M 20.00M 20.00M
Retained earnings - - - - 19356.00M
Other liab - - - 1850.00M 1966.00M
Good will 9256.00M 8946.00M 8926.00M 8970.00M 8905.00M
Other assets - - -10.02816M 833.00M 1365.00M
Cash 1527.00M 1829.00M 1094.00M 980.00M 1575.00M
Cash and equivalents - - - - -
Total current liabilities 3049.00M 2278.00M 2479.16M 2782.00M 2472.00M
Current deferred revenue - 72.84M -0.83980M 89.00M 108.00M
Net debt 3719.00M 3307.00M 4041.00M 4088.00M 2904.00M
Short term debt 655.00M 169.00M 216.00M 168.00M 174.00M
Short long term debt - 101.00M 135.00M 97.00M 107.00M
Short long term debt total 5246.00M 5136.00M 5135.00M 5068.00M 4479.00M
Other stockholder equity - - - 19657.00M 19236.00M
Property plant equipment - - - 4416.00M 4083.00M
Total current assets 6449.00M 6309.00M 5647.00M 5193.00M 5386.00M
Long term investments - 751.00M 319.00M 108.00M 52.00M
Net tangible assets - - - 1018.00M 2143.00M
Short term investments 80.00M 1.00M 7.00M -179.00000M 3.00M
Net receivables 1942.00M 2082.00M 1981.33M 1686.00M 1814.00M
Long term debt - 4538.00M 4594.00M 4541.00M 3966.00M
Inventory 2391.00M 2268.00M 2322.00M 2109.00M 1899.00M
Accounts payable 926.00M 773.00M 811.00M 861.00M 903.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 22014.00M 21533.00M 20597.02M 19657.00M 19236.00M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 855.00M 495.00M 496.15M 243.00M 399.00M
Deferred long term asset charges - - - - -
Non current assets total 25106.00M 24038.00M 23967.00M 24016.00M 22613.00M
Capital lease obligations 509.00M 497.00M 406.00M 430.00M 406.00M
Long term debt total - - - - 4305.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 22.00M -1167.00000M -1094.00000M -1865.00000M -18.00000M
Change to liabilities - - - -48.00000M 60.00M
Total cashflows from investing activities -1344.00000M -1167.00000M -1094.00000M -1865.00000M -1198.00000M
Net borrowings -31.00000M -137.00000M -7.00000M 208.00M -63.00000M
Total cash from financing activities -1119.00000M -322.00000M -211.00000M -8.00000M -123.00000M
Change to operating activities - - - -192.00000M 88.00M
Net income 980.00M 1018.00M 974.00M 335.00M 376.00M
Change in cash -149.00000M 582.00M 114.00M -595.00000M 18.00M
Begin period cash flow 1676.00M 1094.00M 980.00M 1575.00M 1557.00M
End period cash flow 1527.00M 1676.00M 1094.00M 980.00M 1575.00M
Total cash from operating activities 2271.00M 2077.00M 1388.00M 1217.00M 1345.00M
Issuance of capital stock - - - - -
Depreciation 1191.00M 1228.00M 1221.00M 1123.00M 1219.00M
Other cashflows from investing activities -109.00000M -205.00000M -177.30404M - -18.00000M
Dividends paid 166.00M 130.00M 116.00M -100.00000M -54.00000M
Change to inventory -156.00000M -47.00000M -289.25581M -217.00000M -326.00000M
Change to account receivables -129.00000M -55.00000M -117.41011M -164.00000M -198.00000M
Sale purchase of stock -723.00000M -47.00000M -49.00000M - -
Other cashflows from financing activities -134.00000M -55.00000M -39.00000M 2428.00M 3.00M
Change to netincome - - - 380.00M 128.00M
Capital expenditures 543.00M 670.00M 851.00M 745.00M 1180.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -300.00000M -189.00000M -431.21531M -527.00000M -314.00000M
Stock based compensation 162.00M 150.00M 144.00M 140.00M 138.00M
Other non cash items 400.00M -368.00000M -377.78469M 18.00M -116.00000M
Free cash flow 1728.00M 1407.00M 537.00M 472.00M 165.00M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALC
Alcon AG		 0.94 1.44% 66.12 40.56 23.26 3.86 1.80 4.19 16.16
ISRG
Intuitive Surgical Inc		 0.23 0.06% 403.18 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 - -% 192.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -0.49 0.51% 95.87 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 3.21 2.28% 143.92 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon AG

Chemin de Blandonnet 8, Geneva, Switzerland, 1214

Key Executives

Name Title Year Born
Mr. F. Michael Ball Exec. Chairman 1955
Mr. David J. Endicott CEO & Director 1965
Mr. Arthur B. Cummings M.D. Exec. Director 1962
Mr. Timothy C. Stonesifer Chief Financial Officer 1967
Margaret Buckley Chief Accounting Officer NA
Dr. Franck Leveiller Sr. VP, Head of Global R&D and Chief Scientific Officer NA
Ms. Sue-Jean Lin Sr. VP & Chief Information and Transformation Officer 1969
Mr. Royce R. Bedward Sr. VP, Gen. Counsel & Corp. Sec. 1966
Mr. Laurent Attias Head of Corp. Devel., Strategy, BD&L and M&A 1968
Ms. Kimberly Martin Sr. VP & Chief HR Officer 1975

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.